Cystic Fibrosis

Top Story

Top pulmonology news from October: ERS International Congress coverage, effects of e-cigarettes and more

November 8, 2019
In the Journals

Outcomes better with triple therapy in cystic fibrosis with F508del mutation

November 1, 2019
When compared with treatment with tezacaftor plus ivacaftor alone, triple combination therapy with elexacaftor/tezacaftor/ivacaftor improved lung function…
In the Journals

Triple therapy safe, effective in cystic fibrosis with single Phe508del allele

October 31, 2019
Combination therapy with elexacaftor/tezacaftor/ivacaftor improved lung function and the rate of pulmonary exacerbations with minimal adverse effects in patients aged 12…
FDA News

Triple therapy approved to treat cystic fibrosis

October 21, 2019
The FDA announced it has approved elexacaftor/ivacaftor/tezacaftor, the first triple combination therapy for patients with the most common cystic fibrosis mutation. The…
More Headlines »
Special Issue Article

Review of Cystic Fibrosis

Pediatric Annals, April 2019, Volume 48 Issue 4
Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic…
More »
Publication Exclusive
Pharmacology Consult

Changing pharmacotherapeutic trends for cystic fibrosis

Infectious Diseases in Children, November 2015
Edward A Bell, PharmD, BCPS
Cystic fibrosis is one of the most common genetic disorders among whites in the United States, affecting approximately…
More »
Meeting News

VIDEO: Physicians must nurture the engaged patient

April 13, 2019
More »
Healio Jobs